Clinical Trial: Efficacy of Sumatriptan With Naprosyn in Migraine With Aura

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura

Brief Summary: This is a double-blinded placebo study, examining the efficacy of Sumatriptan with Naprosyn in the treatment of migraine with aura.

Detailed Summary:
Sponsor: Dent Neurologic Institute

Current Primary Outcome: Primary outcome measure will be comparative percentage of patients pain free at 2 and 4 hours from initiating treatment with placebo vs treatment with Treximet (sumatriptan with naprosyn). [ Time Frame: 2 and 4 hours ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Secondary outcomes will be percentage of patients with pain relief at 2 and 4 hours. [ Time Frame: 2 and 4 hours ]

Original Secondary Outcome: Same as current

Information By: Dent Neurologic Institute

Dates:
Date Received: May 4, 2009
Date Started: October 2010
Date Completion: December 2015
Last Updated: February 18, 2015
Last Verified: February 2015